Stocktoria
QUEST DIAGNOSTICS INC DGX
NYSE · XNYS · stock · Services-Medical Laboratories · website · IPO 1996-12-17
QUEST DIAGNOSTICS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.0B | $9.9B | $9.3B | $9.9B | $10.8B |
| SG&A expense | $2.0B | $1.8B | $1.6B | $1.9B | $1.7B |
| Operating income | $1.6B | $1.3B | $1.3B | $1.4B | $2.4B |
| Interest expense | — | — | $163.0M | $148.0M | $152.0M |
| Income tax | $314.0M | $273.0M | $248.0M | $264.0M | $597.0M |
| Net income | $992.0M | $871.0M | $854.0M | $946.0M | $2.0B |
| EPS (diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
| Operating cash flow | $1.9B | $1.3B | $1.3B | $1.7B | $2.2B |
| Free cash flow | $1.4B | $909.0M | $864.0M | $1.3B | $1.8B |
| Cash & equivalents | $420.0M | $549.0M | $686.0M | $315.0M | $872.0M |
| Inventory | $189.0M | $188.0M | $190.0M | $192.0M | $208.0M |
| Total assets | $16.2B | $16.2B | $14.0B | $12.8B | $13.6B |
| Shareholders' equity | $7.2B | $6.8B | $6.3B | $5.9B | $6.5B |
Source: SEC EDGAR filings · CIK 0001022079 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.